Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Screening Europe - HTS & Compound Management

Stefan Geschwindner's Biography



Stefan Geschwindner, Principal Scientist, AstraZeneca R&D Molndal

Stefan Geschwindner is a Principal Scientist currently working within Structure, Biophysics and Computational Sciences at AstraZeneca´s R&D site in Mölndal, Sweden. In this role, he is responsible for the implementation and exploitation of label-free methodologies in lead discovery activities. He holds a PhD degree in Biochemistry from University of Frankfurt. Prior to his current position, he was working at the Structural Chemistry department of AstraZeneca in Mölndal, Sweden from 1997 until 2006 where he focused primarily on protein production to secure a high quality protein supply chain with timely delivery into NMR and Crystallography.

Stefan Geschwindner Image

Fragment-informed Lead Generation to Accelerate the Hit Identification for PDE10A Inhibitors: The Synergistic Combination of a Novel Fragment Screening Approach with HTS

Thursday, 30 June 2011 at 11:45

Add to Calendar ▼2011-06-30 11:45:002011-06-30 12:45:00Europe/LondonFragment-informed Lead Generation to Accelerate the Hit Identification for PDE10A Inhibitors: The Synergistic Combination of a Novel Fragment Screening Approach with HTSSELECTBIOenquiries@selectbiosciences.com

Using an innovative and efficient fragment-screening strategy in synergistic combination with an traditional HTS approach can achieve a significant accelaration of hit identification.


Add to Calendar ▼2011-06-30 00:00:002011-07-01 00:00:00Europe/LondonScreening Europe - HTS and Compound ManagementSELECTBIOenquiries@selectbiosciences.com